ATE152470T1 - Modifizierte stärke und verfahren zu ihrer herstellung - Google Patents
Modifizierte stärke und verfahren zu ihrer herstellungInfo
- Publication number
- ATE152470T1 ATE152470T1 AT90121562T AT90121562T ATE152470T1 AT E152470 T1 ATE152470 T1 AT E152470T1 AT 90121562 T AT90121562 T AT 90121562T AT 90121562 T AT90121562 T AT 90121562T AT E152470 T1 ATE152470 T1 AT E152470T1
- Authority
- AT
- Austria
- Prior art keywords
- producing
- starch
- acid
- modified starch
- polyvinylpyrrolidone
- Prior art date
Links
- 229920000881 Modified starch Polymers 0.000 title 1
- 239000004368 Modified starch Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 235000019426 modified starch Nutrition 0.000 title 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- 229920002472 Starch Polymers 0.000 abstract 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- 239000008107 starch Substances 0.000 abstract 2
- 235000019698 starch Nutrition 0.000 abstract 2
- 239000001361 adipic acid Substances 0.000 abstract 1
- 235000011037 adipic acid Nutrition 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000001530 fumaric acid Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000011975 tartaric acid Substances 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH4099/89A CH678920A5 (en, 2012) | 1989-11-14 | 1989-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE152470T1 true ATE152470T1 (de) | 1997-05-15 |
Family
ID=4269806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90121562T ATE152470T1 (de) | 1989-11-14 | 1990-11-10 | Modifizierte stärke und verfahren zu ihrer herstellung |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5409712A (en, 2012) |
| EP (1) | EP0428965B1 (en, 2012) |
| AT (1) | ATE152470T1 (en, 2012) |
| CH (1) | CH678920A5 (en, 2012) |
| DE (1) | DE59010710D1 (en, 2012) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1265320B1 (it) * | 1993-12-22 | 1996-10-31 | Eniricerche Spa | Procedimento per la preparazione di silico-allumine amorfe cataliticamente attive |
| US5656292A (en) * | 1994-06-07 | 1997-08-12 | Alko Group Ltd. | Composition for pH dependent controlled release of active ingredients and methods for producing it |
| DE19729306C2 (de) | 1997-07-09 | 2002-04-04 | Celanese Ventures Gmbh | Stärke und/oder modifizierte Stärke und Weichmacher enthaltende Zusammensetzungen sowie Verfahren und Verwendung |
| US20030013740A1 (en) * | 1998-03-27 | 2003-01-16 | Martin P. Redmon | Stable dosage forms of fluoxetine and its enantiomers |
| US20060093629A1 (en) * | 2004-10-29 | 2006-05-04 | Buehler Gail K | Dye-free pharmaceutical suspensions and related methods |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
| FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
| US4369308A (en) * | 1981-07-24 | 1983-01-18 | National Starch And Chemical Corporation | Low swelling starches as tablet disintegrants |
| DE3320582A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
| US4508740A (en) * | 1983-07-11 | 1985-04-02 | General Foods Corporation | Tabletted beverage composition containing dipeptide sweetener and process therefore |
| US4551177A (en) * | 1984-04-23 | 1985-11-05 | National Starch And Chemical Corporation | Compressible starches as binders for tablets or capsules |
| WO1986007547A1 (en) * | 1985-06-21 | 1986-12-31 | Gerhard Gergely | Process and device for handling processing material and the reaction product manufactured with the aid of the process and/or device |
| IE58401B1 (en) * | 1986-06-20 | 1993-09-08 | Elan Corp Plc | Controlled absorption pharmaceutical composition |
| US4898736A (en) * | 1988-03-09 | 1990-02-06 | Merck & Co., Inc. | Method for tablet preparation |
| IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| US4983399A (en) * | 1989-10-18 | 1991-01-08 | Eastman Kodak Company | Direct compression carrier composition |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
-
1989
- 1989-11-14 CH CH4099/89A patent/CH678920A5/de not_active IP Right Cessation
-
1990
- 1990-11-10 EP EP90121562A patent/EP0428965B1/de not_active Expired - Lifetime
- 1990-11-10 AT AT90121562T patent/ATE152470T1/de not_active IP Right Cessation
- 1990-11-10 DE DE59010710T patent/DE59010710D1/de not_active Expired - Lifetime
- 1990-11-13 US US07/612,919 patent/US5409712A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0428965A1 (de) | 1991-05-29 |
| DE59010710D1 (de) | 1997-06-05 |
| US5409712A (en) | 1995-04-25 |
| CH678920A5 (en, 2012) | 1991-11-29 |
| EP0428965B1 (de) | 1997-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3773926D1 (de) | Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung. | |
| ZA822887B (en) | Process for producing ethylene glycol and/or glycolic acid ester,catalyst composition used therefor,and process for production thereof | |
| DE3871014D1 (de) | Hydroxyaethercarbonsaeuren und ihre lactone, verfahren zu deren herstellung und ihre verwendung als korrosionsinhibitor. | |
| EP0243012A3 (en) | Pyridyl-acrylic acid ester derivatives, process for their preparation and their use as fungicides | |
| DE3574933D1 (de) | Feste arzneizubereitung enthaltend nitrendipin und verfahren zur ihrer herstellung. | |
| ATE67484T1 (de) | Prostaglandinanaloge, verfahren zu ihrer herstellung und ihre pharmazeutischen zusammenstellungen. | |
| ATE116541T1 (de) | Verfahren zur herstellung mikronisierter bioabbaubarer partikel. | |
| ATE152470T1 (de) | Modifizierte stärke und verfahren zu ihrer herstellung | |
| ATE73758T1 (de) | 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel. | |
| DE68923260D1 (de) | Verfahren zur Herstellung eines Derivates der 3,5,6-Trihydroxyhexansäure. | |
| ATE103289T1 (de) | Tylosin- und 10,11,12,13-tetrahydrotylosinderivate, verfahren zu ihrer herstellung und ihre verwendung in pharmazeutischen zusammensetzungen und bei deren herstellung. | |
| HUT58048A (en) | Process for producing 3,3'-dithio-bis(propionic acid) derivatives and their esters, as well as pharmaceutical compositions comprising same | |
| ATE106887T1 (de) | Ester der 10-(1-hydroxy-äthyl)-11-oxo-1- azatricyclo(7.2.0.0(3,8)>undec-2-ene-2- carbonsäure und deren derivate und verfahren zu ihrer herstellung. | |
| ATE121396T1 (de) | Dibenzo(1,5)dioxocin-5-one-derivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung. | |
| DE59010069D1 (de) | Cumarinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und Thiazolyl-essigsäurederivate als Zwischenprodukte | |
| DE59107597D1 (de) | Olefinisch ungesättigte addukte von propylen an mehrfach ungesättigte fettsäuren bzw. fettsäureester, verfahren zu ihrer herstellung und ihre verwendung | |
| PT86344A (de) | Substituierte aminopropionsaeureamide verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte | |
| DE3673708D1 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. | |
| ATE112276T1 (de) | Aryl-chinolyl-substituierte 1,4-dihydropyridin- dicarbonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
| DE3862227D1 (de) | Kristallines quinapril und ein verfahren zu seiner herstellung. | |
| FI883248A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi | |
| FI905930A7 (fi) | Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi | |
| ATE135356T1 (de) | Salicylaldehyd- und salicylsäurederivate sowie deren schwefelanaloge, verfahren und zwischenprodukte zu ihrer herstellung | |
| PT87628A (pt) | Process for the preparation of a fungicidal composition cintaining (2-cyano-2-oxyminoacetyl)-aminoacids derivatives | |
| ATE239017T1 (de) | 1,4-dihydropyridin-5-carbonsäureester-derivate und verfahren zu ihrer herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |